Your trusted partner in renal preclinical research
NEPHRIX Biosolutions is a highly specialized preclinical nephrology CRO (Contract Research Organization) committed to advancing research in the field of renal diseases.
We aims to streamline the preclinical phase of drug development by offering advanced in vitro assays , in vivo models and histology services that accurately forecast clinical outcomes.
Why choose us?
- Exclusive expertise in Kidney and Fibrotic diseases
- Predictive, reproducible, and translational models
- Fast study initiation and adaptable study designs
- High-quality histology and quantitative digital pathology
- Ethical and 3Rs commitment
- Trusted by renowned Pharma, Biotech and Academic partners
In vivo models
Our wide range of animal models are based on original biomarkers analysis to evaluate the early stages of disease progression in rodent models.
In vitro assays
Our renal in vitro models allow the renal cells in culture to express more than 80% of their original characteristics.
Facilities
NEPHRIX Biosolutions is integrated whitin the business incubator PROLOGUE BIOTECH, dedicated to Biotechs and Medical R&D companies. The company also have a close relationship and access to state-of-the-art imaging and molecular facilities of the University Paul Sabatier (Toulouse III). R&D activities are perfomed in independant and dedicated areas with securized access.
- Specific pathogen free (SPF area) animal housing facility (200m2): quarantine + functional evaluation areas
- Cell culture laboratory (P1 and P2 level)
- Molecular biology and Biochemistry laboratories
- Biological samples storage zone (-80°C, -150°C and liquid nitrogen)
- Offices + Secured data archives zone
